Skip to content

Clinical trials

Active, not recruiting Neoplasm Metastasis trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Active, not recruiting Country / region: Brazil Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20151
20193
20201
20217
20226
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Eli Lilly and Company2
Genentech, Inc.2
BioNTech SE1
Celcuity Inc1
European Organisation for Research and Treatment of Cancer - EORTC1
Institut de Recherches Internationales Servier1
M.D. Anderson Cancer Center1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis21
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Carcinoma3
Prostatic Neoplasms3
Colorectal Neoplasms2
Recurrence2
Breast Diseases1
Carcinoma, Renal Cell1
Delirium1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.